Tumour selective Chemothererapy: Cytotoxin-Angiogenesis inhibitor prodrug conjugates mutually activated through bio-redu

Tumour selective Chemothererapy: Cytotoxin-Angiogenesis inhibitor prodrug conjugates mutually activated through bio-redu [ 2004 - 2007 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/252922]

Researchers: A/Pr Michael Kelso (Principal investigator)

Funding Amount $AUD 311,618.33

Funding Scheme Early Career Fellowships

Notes CJ Martin Biomedical ECF

Click to explore relationships graph

Subjects

Medical and Health Sciences | chemotherapy | drug | tumour |

Identifiers